Elnas, Hansel R.

HRN: 13-34-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
03/27/2025
04/03/2025
IV
240mg
OD
S/P CS With Hysterectomy + BTL
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: